Active	Status	Sponsor type	Region	Phase	Filter
2 Active 3 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
zinpentraxin alfa (RG6354) / Roche
STARSCAPE, NCT04552899 / 2020-000791-38: A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis Jan 2024 - Dec 2024: Data from STARSCAPE trial for IPF	Terminated	3	665	Europe, Canada, Japan, US, RoW	PRM-151 (Zinpentraxin Alfa), Placebo	Hoffmann-La Roche	Idiopathic Pulmonary Fibrosis	02/23	02/23
STARSCAPE-OLE, NCT04594707 / 2020-001429-30: A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis	Terminated	3	117	Europe, Canada, Japan, US, RoW	PRM-151 (Zinpentraxin Alfa), Zinpentraxin Alfa	Hoffmann-La Roche	Idiopathic Pulmonary Fibrosis	02/23	02/23